Skip to main content

BNP Paribas Opens Reporting Tool to Agency Lending Clients

bnp-paribas-2014
BNP's DNA platform features a range of risk, performance, investment operations and global fund distribution analytics.

The BNP's DNA platform, accessible through the NeoLink web portal, provides central banks, asset managers, pension funds and insurance companies with a data visualization tool that drills down through volumes of data to highlight insights and trends not immediately apparent from first-order analysis.

"The objective was to provide our clients with an interactive tool that would enhance transparency and improve reporting," says John Amesen, the head of agency lending at BNP Paribas Securities Services. "DNA does this by providing them with a consolidated view of their securities lending programmes. Providing high-end data on performance is crucial in today's financial markets and we are pleased to offer our securities financing clients state-of-the-art technology and data visualization tools."

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@waterstechnology.com or view our subscription options here: https://subscriptions.waterstechnology.com/subscribe

You are currently unable to copy this content. Please contact info@waterstechnology.com to find out more.

Market data costs defy cyclicality

Trading firms continue to grapple with escalating market data costs. Can innovative solutions and strategic approaches bring relief?

AI & data enablement: A looming reality or pipe dream?

Waters Wrap: The promise of AI and agents is massive, and real-world success stories are trickling out. But Anthony notes that firms still need to be hyper-focused on getting the data foundation correct before adding layers.

Most read articles loading...

You need to sign in to use this feature. If you don’t have a WatersTechnology account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here